Nervomatrix website
Israeli back pain device company lands $3.5M investment, plans Akron move (MedCity News)
Israeli pain-relief neurostimulation device company Nervomatrix has received a $3.5 million series A investment and is planning to set up its North American sales and marketing headquarters in Akron, Ohio.
The funding comes entirely from Akron-based Everett Partners, and the Israeli company will use it to establish its base in Akron, and fund product enhancements and post-clinical studies, said Neil Wyant, managing director with Everett. Nervomatrix sprang from an Israeli inc...
